isoxazole-4-boronic acid
Product Information
Molecular Formula
C3H4BNO3
Molecular Weight
112.88
Description
Isoxazole-4-boronic acid is a paramount compound widely employed in the biomedical sector. It assumes a pivotal function in ameliorating diverse ailments by exhibiting potent inhibitory effects on specific oncogenic enzymes that propel malignant tumor genesis and propagation. Moreover, this exceptional product exhibits encouraging efficacy in revolutionizing therapeutic strategies combating infectious maladies. Owing to its extraordinary pharmacological attributes, it emerges as an invaluable asset facilitating expedited drug exploration and refinement endeavors.
Synonyms
Isoxazol-4-ylboronic acid; 1,2-oxazol-4-ylboronic acid; Isoxazole-4-boronicacid; 4-Isoxazolyl-boronic acid; 4-ISOXAZOLEBORONIC ACID; (1,2-oxazol-4-yl)boronic acid; Boronic acid, B-4-isoxazolyl-; isoxazol-4-boronic acid; Isoxazol-4-ylboronicacid; Isoxazole-4-ylboronic acid; B-4-Isoxazolylboronic acid; (1,2-oxazol-4-yl)boronic acid; Isoxazol-4-ylboronic acid; 1-(tert-butoxy carbonyl)-5-phenylpyrrolidine-3-carboxylic acid
IUPAC Name
1,2-oxazol-4-ylboronic acid
SMILES
B(C1=CON=C1)(O)O
InChI
InChI=1S/C3H4BNO3/c6-4(7)3-1-5-8-2-3/h1-2,6-7H
InChI Key
HANPIZQMFCWPKY-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H302 - H319
Precautionary Statement
P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
1
Exact Mass
113.0284232 g/mol
Monoisotopic Mass
113.0284232 g/mol
Topological Polar Surface Area
66.5Ų
Heavy Atom Count
8
Formal Charge
0
Complexity
78.9
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022048684-A1 | Jnk inhibitor, pharmaceutical composition thereof and use thereof | 2020-09-07 |
| WO-2021178780-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 2020-03-06 |
| WO-2021127499-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 2019-12-18 |
| WO-2021007477-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 2019-07-11 |
| CA-3145305-A1 | Indazoles and azaindazoles as lrrk2 inhibitors | 2019-07-11 |
| WO-2020247804-A1 | Heterocycle substituted pyridine derivative antifungal agents | 2019-06-07 |
| CA-3131479-A1 | Pesticidally active diazine-amide compounds | 2019-04-05 |
| CN-113661165-A | Pesticidally active diazine-amide compounds | 2019-04-05 |
| KR-20210149113-A | Insecticidally active diazine-amide compounds | 2019-04-05 |
| WO-2020201079-A1 | Pesticidally active diazine-amide compounds | 2019-03-29 |
